Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in Polyarticular JIA
NCT01261624Phase 2Terminated
- Sponsor
- Italfarmaco
- Start
- Oct 2010
- Primary completion
- Jun 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 7
01
Overview
Phase 2, randomised, open-label trial of givinostat in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Italfarmaco. Primary endpoint: ACR Pediatric Response 30 at 12 weeks. Started Oct 2010; status: terminated.
02
Drugs
givinostat
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT01261624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01261624.